Fenobam promoted the neuroprotective effect of PEP-1-FK506BP following oxidative stress by increasing its transduction efficiency
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
We examined the ways in which fenobam could promote not only the transduction of PEP-1-FK506BP into cells and tissues but also the neuroprotective effect of PEP-1-FK506BP against ischemic damage. Fenobam strongly enhanced the protective effect of PEP-1-FK506BP against H2O2-induced toxicity and DNA fragmentation in C6 cells. In addition, combinational treatment of fenobam with PEP-1-FK506BP significantly inhibited the activation of Akt and MAPK induced by H2O2, compared to treatment with PEP-1-FK506BP alone. Interestingly, our results showed that fenobam significantly increased the transduction of PEP-1-FK506BP into both C6 cells and the hippocampus of gerbil brains. Subsequently, a transient ischemic gerbil model study demonstrated that fenobam pretreatment led to the increased neuroprotection of PEP-1-FK506BP in the CA1 region of the hippocampus. Therefore, these results suggest that fenobam can be a useful agent to enhance the transduction of therapeutic PEP-1-fusion proteins into cells and tissues, thereby promoting their neuroprotective effects.
Abstract
We examined the ways in which fenobam could promote not only the transduction of PEP-1-FK506BP into cells and tissues but also the neuroprotective effect of PEP-1-FK506BP against ischemic damage. Fenobam strongly enhanced the protective effect of PEP-1-FK506BP against H2O2-induced toxicity and DNA fragmentation in C6 cells. In addition, combinational treatment of fenobam with PEP-1-FK506BP significantly inhibited the activation of Akt and MAPK induced by H2O2, compared to treatment with PEP-1-FK506BP alone. Interestingly, our results showed that fenobam significantly increased the transduction of PEP-1-FK506BP into both C6 cells and the hippocampus of gerbil brains. Subsequently, a transient ischemic gerbil model study demonstrated that fenobam pretreatment led to the increased neuroprotection of PEP-1-FK506BP in the CA1 region of the hippocampus. Therefore, these results suggest that fenobam can be a useful agent to enhance the transduction of therapeutic PEP-1-fusion proteins into cells and tissues, thereby promoting their neuroprotective effects.
참고문헌 (27)
- Kang, C. B., "FKBP family proteins: immunophilins with versatile biological functions", Neurosignals, 16, pp.318~325 (2008)
- Kino, T., "FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro", J. Antibiot. (Tokyo), 40, pp.1256~1265 (1987)
- Harrar, Y., "FKBPs: at the crossroads of folding and transduction", Trends Plant Sci, 6, pp.426~431 (2001)
- Brillantes, A. B., "Stabilization of calcium release channel(ryanodine receptor)function by FK506-binding protein", Cell, 77, pp.513~523 (1994)
- Cameron, A. M., "FKBP12 binds the inositol 1,4,5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain", J. Biol. Chem, 272, pp.27582~27588
- Chen, Y. G., "Mechanism of TGFbeta receptor inhibition by FKBP12", EMBO J, 16, pp.3866~3876 (1997)
- Aghdasi, B., "FKBP12, the 12-kDa FK506-binding protein, is a physiologic regulator of the cell cycle", Proc. Natl. Acad. Sci. U. S. A, 98, pp.2425~2430 (2001)
- Shou, W., "Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12", Nature, 391, pp.489~492 (1998)
- Palucha, A., "Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs", Pharmacol. Ther, 115, pp.116~147 (2007)
- Porter, R. H., "Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity", J. Pharmacol. Exp. Ther, 315, pp.711~721 (2005)
- Burke, R. E., "Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease", Pharmacol. Ther, 114, pp.261~277 (2007)
- Hausenloy, D.J., "New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway", Cardiovasc Res, 61, pp.448~460 (2004)
- Kim, S. Y., "Transduced PEP-1-FK506BP ameliorates atopic dermatitis in NC", Nga mice, 2011, pp.131, 1477~1485
- -2-methoxybenzamide, enhances the transduction efficiency of PEP-1-ribosomal protein S3 in vitro and in vivo, "BMB Reports", 2011, 329~334, pp.생화학분자생물학회
- Sohn, E. J., "Effects of pergolide mesylate on transduction efficiency of PEP-1-catalase protein", Biochem. Biophys. Res. Commun, 406, pp.336~340 (2011)
- Koenitzer, J. R, "Redox signaling in inflammation: interactions of endogenous electrophiles and mitochondria in cardiovascular disease", Ann. N Y Acad. Sci, 1203, pp.45~52 (2010)
- Jung Hwan Yoon, "Oxidative modification of ferritin induced by hydrogen peroxide", BMB Reports, 44(3), pp.165~169 (2011), 생화학분자생물학회
- Zweier, J. L, "The role of oxidants and free radicals in reperfusion injury", Cardiovasc. Res, 70, pp.181~190 (2006)
- Sofroniew, M. V, "Astrocytes: biology and pathology", Acta. Neuropathol, 119, pp.7~35 (2010)
- van den Berg, A, "Protein transduction domain delivery of therapeutic macromolecules", Curr. Opin. Biotechnol, 22, pp.888~893 (2011)
- Kim, S. Y., "Transduced PEP-1-FK506BP inhibits the inflammatory response in the Raw 264.7 cell and mouse models", Immunobiology, 216, pp.771~781 (2011)
- Anwyl, R., "Metabotropic glutamate receptors: electrophysiological properties and role in plasticity", Brain Res. Rev, 29, pp.83~120 (1999)
- Niswender, C. M., "Metabotropic glutamate receptors: physiology, pharmacology, and disease", Annu. Rev. Pharmacol. Toxicol, 50, pp.295~322 (2010)
- Lindemann, L., "CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor", J. Pharmacol. Exp. Ther, 339, pp.474~486 (2011)
- Veloz, M. F., "effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice", Genes Brain Behav, 11, pp.326~331 (2012)
- Crock, L. W., "Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception", Mol. Pain, 8, pp.20~ (2012)
- Hwang, I. K., "Changes in the expression of mitochondrial peroxiredoxin and thioredoxin in neurons and glia and their protective effects in experimental cerebral ischemic damage", Free Radic. Biol. Med, 48, pp.1242~1251 (2010)